INEOS has completed the sale of its Melamines & Paraform business to German phenolic resins producer Prefere Resins, the chemicals major said on Monday.
The transaction was announced in April. Financial details were not disclosed.
The sale covers INEOS’ paraform site in Mainz, Germany, as well as the melamines facilities in Springfield, US, Frankfurt in Germany, and Surabaya in Indonesia.
The company said 270 of its employees were being transferred to Prefere.
Prefere Resins is headquartered in Erkner, Germany. It operates production sites in Finland, Germany, the UK, France, Poland and Romania, with a total production capacity of 350,000 tonnes/year and employs over 320 people.
INEOS Enterprises is one of the company’s arms, comprising assets with sales of around €2bn, and it does not belong to INEOS Group Holdings, although it is also privately owned.
Source: ICIS News
Mining, Blue Economy and Maritime Affairs Cabinet Secretary Hassan Ali Joho said the suspension follows the company’s failure to meet requirements under the Mining Act, Cap. 306, the Mining (Licence and Permit) Regulations 2017, the Mining (Royalty Collection and Management) Regulations 2024, and other applicable legal frameworks.
Healthcare Technologies recorded mid-single-digit organic growth on broad-based increase led by personal protection and biopharma, while Water Technologies posted low-single-digit organic growth driven by industrial water and semiconductor markets, partly offset by weakness in the Middle East.
While International Flavors has outperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company’s earnings outlook.
